WO1999048471A1 - Polyalkoxy copolymers as lipase inhibitors and their compositions - Google Patents
Polyalkoxy copolymers as lipase inhibitors and their compositions Download PDFInfo
- Publication number
- WO1999048471A1 WO1999048471A1 PCT/IB1999/000476 IB9900476W WO9948471A1 WO 1999048471 A1 WO1999048471 A1 WO 1999048471A1 IB 9900476 W IB9900476 W IB 9900476W WO 9948471 A1 WO9948471 A1 WO 9948471A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- compositions
- copolymeric
- compound
- copolymeric compound
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 143
- 229920001577 copolymer Polymers 0.000 title claims abstract description 36
- 229940127470 Lipase Inhibitors Drugs 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 69
- 102000004882 Lipase Human genes 0.000 claims abstract description 39
- 108090001060 Lipase Proteins 0.000 claims abstract description 39
- 102000004190 Enzymes Human genes 0.000 claims abstract description 32
- 108090000790 Enzymes Proteins 0.000 claims abstract description 32
- 230000000694 effects Effects 0.000 claims abstract description 31
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 20
- 239000002304 perfume Substances 0.000 claims abstract description 16
- 244000005700 microbiome Species 0.000 claims abstract description 13
- 235000013361 beverage Nutrition 0.000 claims abstract description 10
- 235000013305 food Nutrition 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 238000004321 preservation Methods 0.000 claims abstract description 4
- 230000036758 dandruff formation Effects 0.000 claims abstract 2
- 239000000047 product Substances 0.000 claims description 27
- 239000003921 oil Substances 0.000 claims description 19
- 239000004615 ingredient Substances 0.000 claims description 15
- 229920001983 poloxamer Polymers 0.000 claims description 14
- 239000002250 absorbent Substances 0.000 claims description 11
- 230000002745 absorbent Effects 0.000 claims description 11
- 239000006071 cream Substances 0.000 claims description 6
- 239000002781 deodorant agent Substances 0.000 claims description 6
- 210000000416 exudates and transudate Anatomy 0.000 claims description 5
- 239000004744 fabric Substances 0.000 claims description 5
- 239000006210 lotion Substances 0.000 claims description 5
- 239000002453 shampoo Substances 0.000 claims description 5
- 239000000499 gel Substances 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 230000002421 anti-septic effect Effects 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000011505 plaster Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000004342 Benzoyl peroxide Substances 0.000 claims description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 claims description 2
- 230000003255 anti-acne Effects 0.000 claims description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 claims description 2
- 239000006260 foam Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 150000003431 steroids Chemical class 0.000 claims description 2
- 102000019280 Pancreatic lipases Human genes 0.000 claims 1
- 108050006759 Pancreatic lipases Proteins 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 claims 1
- 229940116369 pancreatic lipase Drugs 0.000 claims 1
- 208000010201 Exanthema Diseases 0.000 abstract description 9
- 201000005884 exanthem Diseases 0.000 abstract description 9
- 206010037844 rash Diseases 0.000 abstract description 9
- 231100000046 skin rash Toxicity 0.000 abstract description 9
- 206010040880 Skin irritation Diseases 0.000 abstract description 3
- 231100000475 skin irritation Toxicity 0.000 abstract description 3
- 230000007794 irritation Effects 0.000 abstract description 2
- 239000004094 surface-active agent Substances 0.000 description 42
- -1 cationic organic compounds Chemical class 0.000 description 38
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 26
- 125000000217 alkyl group Chemical group 0.000 description 23
- 229920001296 polysiloxane Polymers 0.000 description 20
- 235000019198 oils Nutrition 0.000 description 18
- 238000006722 reduction reaction Methods 0.000 description 15
- 235000011187 glycerol Nutrition 0.000 description 12
- 239000002537 cosmetic Substances 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 208000001840 Dandruff Diseases 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 150000004665 fatty acids Chemical class 0.000 description 8
- 150000007513 acids Chemical class 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- 208000002874 Acne Vulgaris Diseases 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 206010000496 acne Diseases 0.000 description 6
- 125000000129 anionic group Chemical group 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000344 soap Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 5
- 150000008051 alkyl sulfates Chemical group 0.000 description 5
- 239000003093 cationic surfactant Substances 0.000 description 5
- 239000003349 gelling agent Substances 0.000 description 5
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 5
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000007859 condensation product Substances 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000003906 humectant Substances 0.000 description 4
- 125000001183 hydrocarbyl group Chemical group 0.000 description 4
- 230000002366 lipolytic effect Effects 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 4
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 239000003945 anionic surfactant Substances 0.000 description 3
- 150000002191 fatty alcohols Chemical class 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 230000003472 neutralizing effect Effects 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 125000001453 quaternary ammonium group Chemical group 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000002888 zwitterionic surfactant Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000002532 enzyme inhibitor Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 2
- 239000001087 glyceryl triacetate Substances 0.000 description 2
- 235000013773 glyceryl triacetate Nutrition 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000014571 nuts Nutrition 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 229920005646 polycarboxylate Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229940071089 sarcosinate Drugs 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 2
- 229960002622 triacetin Drugs 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000007762 w/o emulsion Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229910052726 zirconium Inorganic materials 0.000 description 2
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- OWEGWHBOCFMBLP-UHFFFAOYSA-N 1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one Chemical compound C1=CN=CN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 OWEGWHBOCFMBLP-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- OARDBPIZDHVTCK-UHFFFAOYSA-N 2-butyloctanoic acid Chemical class CCCCCCC(C(O)=O)CCCC OARDBPIZDHVTCK-UHFFFAOYSA-N 0.000 description 1
- WJZIPMQUKSTHLV-UHFFFAOYSA-N 2-ethyldecanoic acid Chemical class CCCCCCCCC(CC)C(O)=O WJZIPMQUKSTHLV-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- PFFITEZSYJIHHR-UHFFFAOYSA-N 2-methyl-undecanoic acid Chemical class CCCCCCCCCC(C)C(O)=O PFFITEZSYJIHHR-UHFFFAOYSA-N 0.000 description 1
- PLVOWOHSFJLXOR-UHFFFAOYSA-N 2-pentylheptanoic acid Chemical class CCCCCC(C(O)=O)CCCCC PLVOWOHSFJLXOR-UHFFFAOYSA-N 0.000 description 1
- APKRDOMMNFBDSG-UHFFFAOYSA-N 2-propylnonanoic acid Chemical class CCCCCCCC(C(O)=O)CCC APKRDOMMNFBDSG-UHFFFAOYSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NEHDRDVHPTWWFG-UHFFFAOYSA-N Dioctyl hexanedioate Chemical compound CCCCCCCCOC(=O)CCCCC(=O)OCCCCCCCC NEHDRDVHPTWWFG-UHFFFAOYSA-N 0.000 description 1
- 239000004150 EU approved colour Substances 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 206010015946 Eye irritation Diseases 0.000 description 1
- 241001096477 Gazania krebsiana subsp. serrulata Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 241000758791 Juglandaceae Species 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 240000006711 Pistacia vera Species 0.000 description 1
- 235000003447 Pistacia vera Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 241000907903 Shorea Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 125000005157 alkyl carboxy group Chemical group 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229960001422 aluminium chlorohydrate Drugs 0.000 description 1
- 150000001399 aluminium compounds Chemical class 0.000 description 1
- 229940001004 aluminium glycinate Drugs 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 229940077746 antacid containing aluminium compound Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 125000005501 benzalkonium group Chemical class 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- RUJUQAPQALJUPC-UHFFFAOYSA-K bis[(2-aminoacetyl)oxy]alumanyl 2-aminoacetate Chemical compound [Al+3].NCC([O-])=O.NCC([O-])=O.NCC([O-])=O RUJUQAPQALJUPC-UHFFFAOYSA-K 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229960003344 climbazole Drugs 0.000 description 1
- 239000011280 coal tar Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- LVYZJEPLMYTTGH-UHFFFAOYSA-H dialuminum chloride pentahydroxide dihydrate Chemical compound [Cl-].[Al+3].[OH-].[OH-].[Al+3].[OH-].[OH-].[OH-].O.O LVYZJEPLMYTTGH-UHFFFAOYSA-H 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- DUCCPNVOQJMMAN-UHFFFAOYSA-N dimethylamino hexanoate Chemical compound CCCCCC(=O)ON(C)C DUCCPNVOQJMMAN-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000003916 ethylene diamine group Chemical class 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 231100000013 eye irritation Toxicity 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- TZMQHOJDDMFGQX-UHFFFAOYSA-N hexane-1,1,1-triol Chemical compound CCCCCC(O)(O)O TZMQHOJDDMFGQX-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229920013818 hydroxypropyl guar gum Polymers 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 231100001032 irritation of the eye Toxicity 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical class OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000008633 juniper tar Substances 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical class C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000010665 pine oil Substances 0.000 description 1
- 229950001046 piroctone Drugs 0.000 description 1
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 1
- 235000020233 pistachio Nutrition 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002189 poly(glycerol 1-O-monomethacrylate) polymer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000010491 poppyseed oil Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- BFZNCPXNOGIELB-UHFFFAOYSA-N propan-2-yl 10-[5,6-dihexyl-2-(8-oxo-8-propan-2-yloxyoctyl)cyclohex-3-en-1-yl]dec-9-enoate Chemical compound CCCCCCC1C=CC(CCCCCCCC(=O)OC(C)C)C(C=CCCCCCCCC(=O)OC(C)C)C1CCCCCC BFZNCPXNOGIELB-UHFFFAOYSA-N 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 229960002026 pyrithione Drugs 0.000 description 1
- YBBJKCMMCRQZMA-UHFFFAOYSA-N pyrithione Chemical compound ON1C=CC=CC1=S YBBJKCMMCRQZMA-UHFFFAOYSA-N 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 150000004023 quaternary phosphonium compounds Chemical class 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- VIDTVPHHDGRGAF-UHFFFAOYSA-N selenium sulfide Chemical compound [Se]=S VIDTVPHHDGRGAF-UHFFFAOYSA-N 0.000 description 1
- 229960005265 selenium sulfide Drugs 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229960005349 sulfur Drugs 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 150000004026 tertiary sulfonium compounds Chemical class 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
- ZNVKGUVDRSSWHV-UHFFFAOYSA-L zinc;4-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=C(S([O-])(=O)=O)C=C1.OC1=CC=C(S([O-])(=O)=O)C=C1 ZNVKGUVDRSSWHV-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/38—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/432—Inhibitors, antagonists
- A61L2300/434—Inhibitors, antagonists of enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
Definitions
- the invention relates to copolymeric compounds and compositions containing these compounds which inhibit lipase enzymes or reduce the lipase enzyme activity.
- lipase enzymes are present on our skin, including enzymes from micro-organisms, enzymes derived from our diet and enzymes produced by the body. It is known that these enzymes can have undesirable effects. For example, these enzymes are believed to cause skin rash and possibly infections of the body, which for example, is a problem encountered by the users of articles which are in contact with the skin and the lipase enzymes thereon, such as bandages, plaster, diapers, incontinence articles, sanitary towels, training pants etc. Also, it is believed that the enzymes can be responsible for the (further) development of dandruff and acne.
- lipase enzymes can be responsible for development of malodour of the body, which can be (partially) due to the production by the enzymes of fatty acids, which are partially eliminated from the body in the body exudates, which can cause a malodour of the body.
- lipase enzymes are essential but may have negative side-effects.
- lipase enzymes are present in detergents to improve the removal of greasy stains, but the presence of active enzyme on the washed fabrics is not desirable.
- Lipase enzymes are present in our digestive system, but it may be desirable that their activity is limited, for example to reduce obesity.
- lipase enzyme inhibitors are known in the art.
- antibodies which are specific to certain lipase enzymes are used, such as described in WO 95/24896 and WO 95/01155.
- EP 0117632-B relates to disposable articles which comprise lipase inhibiting agents, preferably zinc containing components, and a vehicle material.
- US 3,091,241 relates to the use of triacetin in vaginal tampons to inhibit lipase enzyme activity.
- US 3, 961,486 teaches the use of adipic acid to reduce the lipase enzyme activity and to reduce the skin rash
- copolymeric compounds having a backbone comprising one or more linear alkoxy units and one or more branched alkoxy units, can very effectively inhibit lipase enzymes, or reduce the lipolytic enzyme activity.
- the compounds have been found to be useful in various applications where reduction of the lipolytic enzyme activity is desired.
- the inventors have found that the compounds can inhibit lipase enzymes from various micro-organisms, including bacteria, and that the compounds can thus reduce the activity of the micro-organisms and reduce the problems caused by these micro organisms.
- the use on the skin of the compounds or compositions containing the compounds results in a very effective reduction or a prevention of skin rash or skin irritation and also of acne; it has also been found that the compositions or compounds can reduce the irritation of the eyes; it has been found that the compounds or compositions thereof are also able to reduce or prevent malodour of the body; it has been found that the compounds or compositions containing the compound are capable of reducing or preventing dandruff; it has also been found that the compositions or compounds can improve the longevity of a perfume, e.g. protect the perfume esters from degradation by the enzymes; it has also been found that the compositions or compounds can improve the preservation of food and beverage products; it has also been found that the compositions or compounds can improve the healing of wounds.
- compositions for the reduction of the lipase enzyme activity comprising a copolymeric compound of average molecular weight of at least 400, having a polyalkoxy backbone which comprises at least one branched C ⁇ -C 30 alkoxy unit and at least one linear C ⁇ -C 3 o alkoxy unit.
- the invention also relates to the use of these copolymeric compounds for preparation of compositions for reduction of the lipolytic enzyme activity, in particular of lipase enzymes derived from micro-organisms, in particular of micro-organisms in contact with the hair or skin.
- copolymeric compounds of the invention reduce the enzyme activity of lipase enzymes, by inactivating the enzymes.
- the invention is concerned with the use of the copolymeric compounds described hereinafter, for preparation of compositions to inhibit or reduce the lipase enzyme activity.
- the lipase enzymes can be from micro-organisms, such as bacteria, fungi, yeast, or can be produced by the human or animal body, or can be derived from the diet or can be derived from products comprising lipase enzymes.
- lipase enzymes The general activity of lipase enzymes is to hydrolyse fats present in the ester form (such as the glycerides found in human skin), and accordingly generate fatty acids and glycerol, which can be a source of energy in the body but also can cause irritation, dandruff and malodour of the body. Because this group of enzymes is so widely distributed in micro- organisms, such as bacterias, fungi and yeast, in animals, in humans, also in the body exudates, they are almost always present in or on the human or animal body.
- the compounds or compositions thereof can be used in any application where reduction of the enzyme activity of these enzymes is required.
- the copolymeric compounds are used for preparation of compositions for reduction of the lipase enzyme activity, in particular of micro-organisms, including the reduction of bacterial lipase enzyme activity.
- compositions are used for reduction of the enzyme activity of lipase enzymes in contact with the human or animal body, in particular the skin or hair, but also for reduction of the enzyme activity in food products and beverages, reduction of the enzyme activity of micro-organisms present on fabrics and surfaces, such as in kitchens and bathrooms.
- the compositions or the compounds of the invention are useful in personal-care products, cleaning products, food and beverage products.
- the compositions also include eye-care products such as eye drops, hair conditioners, hair styling products, antiseptic compositions, perfume compositions, tooth care products, and the compositions can be used in absorbent articles.
- the compounds may also be used to inhibit active lipase enzymes which remain on the fabric or in the washing water after the washing or cleaning process.
- the compounds or compositions of the invention may also be useful for reduction of the enzyme activity of digestive lipolytic enzymes.
- the compounds may be used to treat obesity.
- the compounds or the compositions are used for reduction of the enzyme activity of lipase enzymes of micro-organisms, in particular bacterial lipase enzymes which can cause skin rash or skin irritation, infected skin, acne, malodour of the body and dandruff or which can cause decaying or rotting of food products and beverages, and reduce the longevity of perfumes.
- the compounds or compositions can be used to treat various problems caused by lipase enzymes, including skin rash, acne, dandruff, malodour of the body or the copolymeric compound or composition can be used for preservation of food or beverage products, but also to increase the life of a perfume, e.g. the longevity of a perfume by reducing the degradation of the perfume esters by the lipase enzymes, and also to improve wound healing and reduce eye irritation.
- treatment is meant herein an improvement of the affected human or animal body, caused by the enzyme activity.
- the amount of the compounds of the invention or the compositions for the reduction of the lipase enzyme activity or in the treatment will vary with the particular location of the condition being treated, the severity of the condition being treated, the expected duration of the treatment, any specific sensitivity to either the composition specific to the user, the condition of the user, concurrent therapies being administered, other conditions present in the user.
- a minimum inhibitory concentration of the compounds of the invention or the compositions thereof is used, in an amount and form such that it is available to inhibit the activity of the lipase enzymes, for example topically applied to the skin or hair, eyes or teeth, or orally taken by the user, or applied on surfaces or fabrics.
- compositions which may be cosmetic compositions, preferably in the form of a spray, cream, foam, lotion, gel, oil, ointment or powder or tablet, preferably in the form of a water-in-oil emulsion.
- compositions are comprised in a shampoo, deodorant or absorbent articles, such as diapers, tissues, wet wipes, as described herein. Also highly preferred are perfume compositions, cleaning compositions, hair-care compositions, eye-care compositions.
- compositions may comprise additional ingredients and the exact nature and levels of the additional ingredients will depend on the application of the compounds of the invention or the compositions thereof.
- Highly preferred additional components of the compositions of the invention may be bactericidal or fungicidal agents, anti-dandrufF agents, and/ or other enzyme inhibitors.
- Anti-bodies against enzymes may be present, but because of the nature of the copolymeric compounds in accord with the invention, they may be omitted from the compositions.
- surfactants may be included, and in skin-care products zinc-containing compounds may be used.
- compositions herein are steroid-containing compositions. Also highly preferred compositions herein anti-acne ingredients, preferably benzoyl peroxide.
- the copolymeric compound of the invention comprises a poly alkoxy backbone, comprising at least one branched C_-C 3 o alkoxy unit and at least one linear C ⁇ -C 3 o alkoxy unit.
- the copolymer comprises a backbone having at least one branched C ⁇ -C 2 alkoxy unit and at least one linear C ⁇ -C 24 alkoxy unit, more preferably at least one branched C_-C ⁇ alkoxy unit and at least one linear C_-C_ alkoxy unit, and even more preferably at least one branched C_-C ⁇ alkoxy unit and at least one linear Ci-C ⁇ alkoxy unit.
- the backbone comprising a condensation product of propylene glycol and ethylene glycol units.
- the copolymeric backbone comprises of from 5% to 95%, more preferably from 10% to 90%, more preferably from 40% to 90%, even more preferably from 60% to 90%, most preferably from 70% to 90% by weight of branched alkoxy units and of from 5% to 95%, more preferably from 10% to 90%, more preferably from 10% to 60%, even more preferably from 10% to 40%, most preferably from 10 % to 30% by weight linear alkoxy units.
- the copolymeric compound has an average molecular weight of at least 400, preferably from 600 or 800 to 200,000, more preferably from 900 to 70,000 or even to 10,000, or even from 1000 to 8500. It may be preferred that when 40% by weight of the backbone is a ethoxy unit, the compound has a relatively low average molecular weight, i.e. the average molecular weight of the compound is no more than 4500.
- Highly preferred copolymeric compounds are polyethylene glycol polypropylene glycol copolymers, available from BASF under the tradename Pluronic and from ICI under the tradename Synperonic.
- Pluronic 6800 Preferred are Pluronic 6800, Synperonic 75, 85 or 38. Highly preferred are Pluronic 3100, 4300, 6100, 6200, 8100, 10100 and Synperonic 31, 62, 44, 101 and in particular Synperonic 81, 42, and 25R2. Pluronic 9400 may be a less preferred compound for use herein. Also highly preferred are Pluronic 9200, 9400 and 10500, and Synperonic 31, 61, 62, 44, 64, 94 and 105. Mixtures of these compounds may also be used.
- the copolymeric compound is preferably present at a level of from 0.01% to 50% by weight of the composition, more preferably from 0.1% to 30% by weight of the composition, even more preferably from 0.5% to 10% by weight of the composition.
- compositions as described herein in particular hair-care products, cosmetic products including skin-care products, deodorants, perfumes, cleaning products, food 8
- the level of the compounds herein is preferably from 0.05% or 0.1% to 5%, more preferably from 0.1% to 3%, or even from 0.1% to 2% or even from 0.1% to 1% or even to 0.5% by weight of the composition.
- compositions herein can be prepared by any method known in the art for preparation for cosmetic compositions or medicament. The exact method will depend on the nature of the composition.
- the copolymer can be added to the compositions separately, or for example be combined with other ingredients commonly used in cosmetic compositions or medicaments, or for example dispersed or dissolved in water or oil or a water-in-oil emulsion prior to addition to the composition.
- compositions of the invention can be in the form of cleaning compositions or food or beverage products.
- the compositions may be used directly for the relevant purpose or may be added to other products or compositions.
- compositions can also be in the form of personal-care compositions or products.
- the composition of the invention can be administered to the user by any method known in the art, depending on the application of the composition and the purpose of use. It may be preferred that the composition is applied to the skin or hair, which will be in contact with, or the vicinity of the lipase enzymes. It may be preferred that the composition is administered orally to the user.
- the composition When the composition is used for treatment of malodour of the body, the composition may preferably be in the form of a deodorant composition, in the form of a fluid, gel, cream or powder, contained in a stick or spray.
- the composition When the composition is used for treatment of dandruff, the composition may preferably be in the form of a shampoo or conditioner composition.
- the composition When the composition is used for treatment of dermatitis, acne or skin rash, the composition may preferably be in the form of cream or lotion or aftershave, preferably comprising an alcohol, preferably a mixture of ethanol in water, and preferably also comprising a perfume component.
- compositions can also be applied (firstly) to an article, which will then be applied to the skin.
- compositions of the present invention is preferably comprised in an absorbent article, preferably a disposable absorbent article.
- absorbent articles refers to devices which absorb and contain body exudates or blood, and, more specifically, refers to devices which are placed against or in proximity to the body of the wearer to absorb and contain the various exudates discharged from the body.
- dispenser is used herein to describe absorbent articles which are not intended to be laundered or otherwise restored or reused as an absorbent article (i.e., they are intended to be discarded after a single use and, preferably, to be recycled, composted or otherwise disposed of in an environmentally compatible manner).
- the structure of the disposable absorbent article is not critical to the practice of the present invention.
- the composition is incorporated into the absorbent article or diaper in particular in an amount which will deliver the required treatment or reduction or inhibition of the enzyme activity, whereby it may be preferred that this is achieved after frequent use.
- the disposable absorbent article preferably contains the composition according to the invention at a level such that the copolymeric compounds therein are present at a level of from 0.01 % to 30%, more preferably from 0.01% to 10%, most preferably from 0.05% to 5% by weight of the article, or even from 0.1% to 5%, more preferably from 0.1% to 3%, or even from 0.1% to 2% or even from 0.1% to 1% or even to 0.5% by weight.
- Highly preferred articles are bandages, plaster, wipes, catamenials and diapers, or also tissue and tampons.
- composition of the invention can comprise additional ingredients. Which ingredients are present and at which level depends on the character of the composition and the use thereof. Highly preferred ingredients are surfactants.
- compositions comprise one or more other ingredient which can reduce dermatitis or compounds which can help the healing of the skin, such as triacetin, benzalkonium salts, metal-containing compounds, in particular zinc-containing compounds, vitamins and cortisone' s, and also compounds to soften the skin such as vaseline, glycerin, triethyleneglycol, lanolin, paraffin and another group of polymers extensively employed by pharmaceutical and cosmetic manufactures, as also described herein.
- cationic organic compounds such as cationic surfactants.
- the compositions comprise one or more other ingredient which can reduce dermatitis or compounds which can help the healing of the skin, such as triacetin, benzalkonium salts, metal-containing compounds, in particular zinc-containing compounds, vitamins and cortisone' s, and also compounds to soften the skin such as vaseline, glycerin, triethyleneglycol, lanolin, paraffin and another group of polymers extensively employed by pharmaceutical and cosmetic manufactures, as also described herein.
- the skin care or cosmetic compositions can be in the form of creams, sprays, lotions, gels, and the like.
- the cosmetic compositions herein are in the form of an oil-in- water emulsion of one or more oil phases in an aqueous continuous phase, each oil phase comprising a single oily component or a mixture of oily components in miscible or homogeneous form but said different oil phases containing different materials or combinations of materials from each other.
- compositions of the invention is preferably from about 0.1% to about 60%, preferably from about 1% to about 30% and more preferably from about 1% to about 10% by weight.
- compositions preferably comprise, as either all or a portion of the oil phase or oil phases referred to above a first silicone-containing phase comprising a crosslinked polyorganosiloxane polymer and a silicone oil, wherein the composition comprises 0.1% to about 20%, preferably from about 0.5% to about 10%, more preferably from about 0.5%) to about 5%, by weight of composition, of the combination of crosslinked silicone and silicone oil.
- compositions herein preferably also comprise a second non-crosslinked silicone- containing phase.
- the second silicone-containing phase is present in a level of from about 0.1% to about 20%, especially from about 0.1% to about 10% by weight of composition.
- Suitable silicone fluids for use in the second silicone-containing phase herein include water-insoluble silicones inclusive of non-volatile polyalkyl and polyaryl siloxane gums and fluids, volatile cyclic and linear polyalkylsiloxanes, polyalkoxylated silicones, amino and quaternary ammonium modified silicones, and mixtures thereof.
- the second silicone-containing phase comprises a silicone gum or a mixture of silicones including the silicone gum.
- silicone gum means high molecular weight silicone-based fluids having a mass-average molecular weight in excess of about 200,000 and preferably from about 200,000 to about 400,000. Silicone oils generally have a molecular weight of less than about 200,000. Typically, silicone gums have a viscosity at 25°C in excess of about 1,000,000 mm ⁇ .s'l.
- the silicone gums include dimethicones as described by Petrarch and others including US-A- 4,152,416, May 1, 1979 to Spitzer, et al, and Noll, Walter, Chemistrv and Technology of Silicones. New York: Academic Press 1968. Also describing silicone gums are General Electric Silicone Rubber Product Data Sheets SE 30, SE 33, SE 54 and SE 76. 12
- another, third, oil phase is present in an amount of from about 0.1% to about 15%, more preferably from about 1% to about 10% by weight of composition.
- the third oil phase can be either a separate phase or can form one phase together with either or both of the first and second silicone phases.
- the third oil phase is a separate phase.
- This oil phase preferably comprises a non-silicone organic oil, such as a natural or synthetic oil selected from mineral, vegetable, and animal oils, fats and waxes, fatty acid esters, fatty alcohols, fatty acids and mixtures thereof, which ingredients are useful for achieving emollient cosmetic properties.
- a non-silicone organic oil such as a natural or synthetic oil selected from mineral, vegetable, and animal oils, fats and waxes, fatty acid esters, fatty alcohols, fatty acids and mixtures thereof, which ingredients are useful for achieving emollient cosmetic properties.
- Suitable first oil phase components for use herein include, for example, optionally hydroxy-substituted Cg-C5o unsaturated fatty acids and esters thereof, beeswax, saturated and unsaturated fatty alcohols such as behenyl alcohol and cetyl alcohol, hydrocarbons such as mineral oils, petrolatum and squalane, fatty sorbitan esters (see US- A-3988255, Seiden, issued October 26 1976), lanolin and lanolin derivatives, animal and vegetable triglycerides such as almond oil, peanut oil, wheat germ oil, linseed oil, jojoba oil, oil of apricot pits, walnuts, palm nuts, pistachio nuts, sesame seeds, rapeseed, cade oil, corn oil, peach pit oil, poppyseed oil, pine oil, castor oil, soybean oil, avocado oil, safflower oil, coconut oil, hazelnut oil, olive oil, grapeseed oil, shea butter, shorea butter,
- non-occlusive moisturizers such as non-occlusive moisturizers, humectants, gelling agents, neutralizing agents, perfumes, colouring agents and surfactants, can be added to the skin compositions herein. 13
- compositions herein can comprise a humectant.
- Suitable humectants for use herein include sorbitol, propylene glycol, butylene glycol, hexylene glycol, ethoxylated glucose derivatives, hexanetriol, glycerine, glycine, hyaluronic acid, arginine, Ajidew (NaPCA), water-soluble polyglycerylmethacrylate lubricants and panthenols.
- a preferred humectant herein is glycerine (sometimes known as glycerol or glycerin). Chemically, glycerine is 1,2,3-propanetriol and is a product of commerce.
- Glycerine is especially preferred in the compositions of the invention from the viewpoint of boosting moisturisation. Also preferred for use herein is butylene glycol. Particularly preferred from the viewpoint of boosting moisturisation is a combination of glycerine and urea.
- compositions of the invention can also contain a hydrophilic gelling agent at a level preferably from about 0.01% to about 10%.
- the gelling agent preferably has a viscosity (1% aqueous solution, 20°C, Brookfield RVT) of at least about 4000 mPa.s, more preferably at least about 10,000 mPa.s and especially at least 50,000 mPa.s.
- Suitable hydrophilic gelling agents can generally be described as water-soluble or colloidally water-soluble polymers, and include cellulose ethers (e.g. hydroxyethyl cellulose, methyl cellulose, hydroxypropylmethyl cellulose), polyvinylpyrrolidone, polyvinylalcohol, guar gum, hydroxypropyl guar gum and xanthan gum.
- cellulose ethers e.g. hydroxyethyl cellulose, methyl cellulose, hydroxypropylmethyl cellulose
- polyvinylpyrrolidone polyvinylalcohol
- guar gum hydroxypropyl guar gum
- xanthan gum xanthan gum
- Neutralizing agents suitable for use in neutralizing acidic group containing hydrophilic gelling agents herein include sodium hydroxide, potassium hydroxide, ammonium hydroxide, monoethanolamine, diethanolamine and triethanolamine.
- the pH of the compositions is preferably from about 4 to about 9, more preferably from about 6 to about 8.0.
- the balance of the cosmetic composition is water or an aqueous carrier suitable for topical application to the skin.
- the water content of the compositions herein is generally 14
- compositions of the invention are preferably in the form of a moisturising cream or lotion, which can be applied to the skin as a leave-on product.
- compositions herein are one or more surfactants.
- salicylic acid In hair-care compositions, such as shampoos, it may be preferred that salicylic acid, selenium sulfide, sulfur, zinc pyrithione, coal tar or mixtures thereof are present. Also preferred may be the incorporation of alkyl isoquinolinium bromide, benzethonium chloride, magnesium, omadine, climbazole, octopirox and/or ketoconazole. These ingredients may be present at any suitable level, preferably being from 0.01% to about 10%, preferably 0.05% to 5% or more preferably from 0.05 % to 3% or even to 2% or even to 5% by weight of the hair-care composition.
- a perfume is present, preferably combined with additional perfume longevity increasing aids or residuality improving aids, including di-octyl adipate and or Farnisol.
- additional perfume longevity increasing aids or residuality improving aids including di-octyl adipate and or Farnisol.
- triclosan zinc phenol sulphonate
- propylene glygol and/ or dipropylene glycol.
- Useful may also be aluminium compounds such as aluminium chloride, aluminium chlorohydrate and including zirconium and /or zirconium aluminium glycinate, or mixtures thereof.
- These ingredients may be present at any suitable level, preferably being from 0.01% to about 10%, preferably 0.05% to 5% or more preferably from 0.05 % to 3% or even to 2% or even to 5% by weight of the deodorant composition.
- anionic surfactants useful for detersive purposes can be comprised in the detergent composition. These can include salts (including, for example, sodium, 15
- potassium, ammonium, and substituted ammonium salts such as mono-, di- and triethanolamine salts
- anionic sulfate, sulfonate, carboxylate and sarcosinate surfactants are preferred.
- surfactants systems comprising a sulfonate and a sulfate surfactant, preferably a linear or branched alkyl benzene sulfonate and alkyl ethoxylsulfates, as described herein, preferably combined with a cationic surfactants as described herein.
- anionic surfactants include the isethionates such as the acyl isethionates, N-acyl taurates, fatty acid amides of methyl tauride, alkyl succinates and sulfosuccinates, monoesters of sulfosuccinate (especially saturated and unsaturated C 1 ? -C ⁇ ⁇ monoesters) diesters of sulfosuccinate (especially saturated and unsaturated C fi -C 14 diesters), N-acyl sarcosinates.
- Resin acids and hydrogenated resin acids are also suitable, such as rosin, hydrogenated rosin, and resin acids and hydrogenated resin acids present in or derived from tallow oil.
- Anionic sulfate surfactants suitable for use herein include the linear and branched primary and secondary alkyl sulfates, alkyl ethoxysulfates, fatty oleoyl glycerol sulfates, alkyl phenol ethylene oxide ether sulfates, the C5-C17 acyl-N-(Cj-C4 alkyl) and -N-(Cj-C2 hydroxyalkyl) glucamine sulfates, and sulfates of alkylpolysaccharides such as the sulfates of alkylpolyglucoside (the nonionic nonsulfated compounds being described herein).
- Alkyl sulfate surfactants are preferably selected from the linear and branched primary Ci ⁇ "Ci8 alky ⁇ sulfates, more preferably the C ⁇ -C ⁇ - ⁇ branched chain alkyl sulfates and the C12-C14 linear chain alkyl sulfates.
- Alkyl ethoxysulfate surfactants are preferably selected from the group consisting of the ClO"Cl8 a - ⁇ y- sulfates which have been ethoxylated with from 0.5 to 20 moles of ethylene oxide per molecule. More preferably, the alkyl ethoxysulfate surfactant is a C ⁇ ⁇ - 16
- Cj8 most preferably C ⁇ ⁇ -C ⁇ 5 alkyl sulfate which has been ethoxylated with from 0.5 to 7, preferably from 1 to 5, moles of ethylene oxide per molecule.
- Anionic sulfonate surfactants suitable for use herein include the salts of C5-C20 linear alkylbenzene sulfonates, alkyl ester sulfonates, Cg-C22 primary or secondary alkane sulfonates, Cg-C24 olefin sulfonates, sulfonated polycarboxylic acids, alkyl glycerol sulfonates, fatty acyl glycerol sulfonates, fatty oleyl glycerol sulfonates, and any mixtures thereof.
- Suitable anionic carboxylate surfactants include the alkyl ethoxy carboxylates, the alkyl polyethoxy polycarboxylate surfactants and the soaps ('alkyl carboxyls'), especially certain secondary soaps as described herein.
- Suitable alkyl ethoxy carboxylates include those with the formula RO(CH2CH2 ⁇ ) x CH2C00 " M + wherein R is a to Cjg alkyl group, x ranges from O to 10, and the ethoxylate distribution is such that, on a weight basis, the amount of material where x is 0 is less than 20 % and M is a cation.
- Suitable alkyl polyethoxy polycarboxylate surfactants include those having the formula RO-(CHR ⁇ -CHR2-O)-R3 wherein R is a Cg to Ci g alkyl group, x is from 1 to 25, R ⁇ and R2 are selected from the group consisting of hydrogen, methyl acid radical, succinic acid radical, hydroxysuccinic acid radical, and mixtures thereof, and R3 is selected from the group consisting of hydrogen, substituted or unsubstituted hydrocarbon having between 1 and 8 carbon atoms, and mixtures thereof.
- Suitable soap surfactants include the secondary soap surfactants which contain a carboxyl unit connected to a secondary carbon.
- Preferred secondary soap surfactants for use herein are water-soluble members selected from the group consisting of the water-soluble salts of 2-methyl-l-undecanoic acid, 2-ethyl-l-decanoic acid, 2-propyl-l-nonanoic acid, 2-butyl-l-octanoic acid and 2-pentyl-l-heptanoic acid. 17
- alkali metal sarcosinates of formula R-CON (R 1 ) CH2 COOM, wherein R is a C5-C17 linear or branched alkyl or alkenyl group, R 1 is a C1-C4 alkyl group and M is an alkali metal ion.
- R is a C5-C17 linear or branched alkyl or alkenyl group
- R 1 is a C1-C4 alkyl group
- M is an alkali metal ion.
- any alkoxylated nonionic surfactants are suitable herein.
- the ethoxylated and propoxylated nonionic surfactants are preferred.
- Preferred alkoxylated surfactants can be selected from the classes of the nonionic condensates of alkyl phenols, nonionic ethoxylated alcohols, nonionic ethoxylated/propoxylated fatty alcohols, nonionic ethoxylate/propoxylate condensates with propylene glycol, and the nonionic ethoxylate condensation products with propylene oxide/ethylene diamine adducts.
- the condensation products of aliphatic alcohols with from 1 to 25 moles of alkylene oxide, particularly ethylene oxide and/or propylene oxide, are suitable for use herein.
- the alkyl chain of the aliphatic alcohol can either be straight or branched, primary or secondary, and generally contains from 6 to 22 carbon atoms.
- Particularly preferred are the condensation products of alcohols having an alkyl group containing from 8 to 20 carbon atoms with from 2 to 10 moles of ethylene oxide per mole of alcohol.
- Polyhydroxy fatty acid amides suitable for use herein are those having the structural formula R 2 CONR ⁇ Z wherein : Rl is H, C1-C4 hydrocarbyl, 2-hydroxy ethyl, 2-hydroxy propyl, ethoxy, propoxy, or a mixture thereof, preferable C1-C4 alkyl, more preferably C ⁇ or C2 alkyl, most preferably C ⁇ alkyl (i.e., methyl); and R2 is a C5-C31 hydrocarbyl, preferably straight-chain C5-C19 alkyl or alkenyl, more preferably straight-chain C9-C17 18
- alkyl or alkenyl most preferably straight-chain C ⁇ ⁇ -Cu alkyl or alkenyl, or mixture thereof; and Z is a polyhydroxyhydrocarbyl having a linear hydrocarbyl chain with at least 3 hydroxyls directly connected to the chain, or an alkoxylated derivative (preferably ethoxylated or propoxylated) thereof.
- Z preferably will be derived from a reducing sugar in a reductive amination reaction; more preferably Z is a glycityl.
- Suitable fatty acid amide surfactants include those having the formula: R 6 CON(R ⁇ )2 wherein R ⁇ is an alkyl group containing from 7 to 21, preferably from 9 to 17 carbon atoms and each R ⁇ is selected from the group consisting of hydrogen, Ci -C4 alkyl, C j - C4 hydroxyalkyl, and -(C2H4O) x H, where x is in the range of from 1 to 3.
- Suitable alkylpolysaccharides for use herein are disclosed in U.S. Patent 4,565,647, Llenado, issued January 21, 1986, having a hydrophobic group containing from 6 to 30 carbon atoms and a polysaccharide, e.g., a polyglycoside, hydrophilic group containing from 1.3 to 10 saccharide units.
- Preferred alkylpolyglycosides have the formula:
- R 2 is selected from the group consisting of alkyl, alkylphenyl, hydroxyalkyl, hydroxyalkylphenyl, and mixtures thereof in which the alkyl groups contain from 10 to 18 carbon atoms; n is 2 or 3; t is from 0 to 10, and x is from 1.3 to 8.
- the glycosyl is preferably derived from glucose.
- Suitable amphoteric surfactants for use herein include the amine oxide surfactants and the alkyl amphocarboxylic acids. 19
- Suitable amine oxides include those compounds having the formula R ⁇ (OR4) X N ⁇ (R ⁇ )2 wherein R ⁇ is selected from an alkyl, hydroxyalkyl, acylamidopropoyl and alkyl phenyl group, or mixtures thereof, containing from 8 to 26 carbon atoms; R ⁇ is an alkylene or hydroxyalkylene group containing from 2 to 3 carbon atoms, or mixtures thereof; x is from 0 to 5, preferably from 0 to 3; and each R ⁇ is an alkyl or hydroxyalkyl group containing from 1 to 3, or a polyethylene oxide group containing from 1 to 3 ethylene oxide groups.
- Preferred are Cio-Cjg alkyl dimethylamine oxide, and CJO-18 acylamido alkyl dimethylamine oxide.
- a suitable example of an alkyl aphodicarboxylic acid is Miranol(TM) C2M Cone, manufactured by Miranol, Inc., Dayton, NJ.
- Zwitterionic surfactants can also be incorporated into the detergent compositions in accord with the invention. These surfactants can be broadly described as derivatives of secondary and tertiary amines, derivatives of heterocyclic secondary and tertiary amines, or derivatives of quaternary ammonium, quaternary phosphonium or tertiary sulfonium compounds. Betaine and sultaine surfactants are exemplary zwitterionic surfactants for use herein.
- Suitable betaines are those compounds having the formula R(R')2N + R2COO " wherein R is a Cg-Cjg hydrocarbyl group, each Rl is typically C1-C3 alkyl, and R 2 is a C1-C5 hydrocarbyl group.
- Preferred betaines are C 12- 18 dimethyl-ammonio hexanoate and the Ci ⁇ -18 acylamidopropane (or ethane) dimethyl (or diethyl) betaines.
- Complex betaine surfactants are also suitable for use herein.
- Suitable cationic surfactants to be used herein include the quaternary ammonium surfactants.
- the quaternary ammonium surfactant is a mono C6-C ⁇ g, preferably C ⁇ -Ci 0 N-alkyl or alkenyl ammonium surfactants wherein the remaining N 20
- positions are substituted by methyl, hydroxyethyl or hydroxypropyl groups.
- Preferred are also the mono-alkoxylated and bis-alkoxylated amine surfactants.
- cationic ester surfactants Another suitable group of cationic surfactants which can be used in the detergent compositions or components thereof herein are cationic ester surfactants.
- the cationic ester surfactant is a, preferably water dispersible, compound having surfactant properties comprising at least one ester (i.e. -COO-) linkage and at least one cationically charged group.
- Suitable cationic ester surfactants, including choline ester surfactants have for example been disclosed in US Patents No.s 4228042, 4239660 and 4260529.
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT99942578T ATE275932T1 (en) | 1998-03-24 | 1999-03-22 | USE OF CERTAIN POLYALKOXY COMPOLYMERS FOR THE TREATMENT OF DANDRUFF |
BR9909064-3A BR9909064A (en) | 1998-03-24 | 1999-03-22 | Polyalkoxy copolymers as lipase inhibitors and their compositions |
DE69920194T DE69920194T2 (en) | 1998-03-24 | 1999-03-22 | Use of certain polyalkoxycopolymers for the treatment of dandruff |
AU32700/99A AU3270099A (en) | 1998-03-24 | 1999-03-22 | Polyalkoxy copolymers as lipase inhibitors and their compositions |
US09/646,292 US6461601B1 (en) | 1998-03-24 | 1999-03-22 | Polyalkoxy copolymers as lipase inhibitors and their compositions |
EP99942578A EP1066025B1 (en) | 1998-03-24 | 1999-03-22 | Use of certain polyalkoxy copolymers for the treatment of dandruff |
JP2000537522A JP2002507559A (en) | 1998-03-24 | 1999-03-22 | Polyalkoxy copolymers as lipase inhibitors and their compositions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9806235A GB2335596A (en) | 1998-03-24 | 1998-03-24 | Polyalkyleneglycol Copolymers as Lipase Inhibitors |
GB9806235.9 | 1998-03-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999048471A1 true WO1999048471A1 (en) | 1999-09-30 |
Family
ID=10829125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB1999/000476 WO1999048471A1 (en) | 1998-03-24 | 1999-03-22 | Polyalkoxy copolymers as lipase inhibitors and their compositions |
Country Status (10)
Country | Link |
---|---|
US (1) | US6461601B1 (en) |
EP (1) | EP1066025B1 (en) |
JP (1) | JP2002507559A (en) |
CN (1) | CN1295460A (en) |
AT (1) | ATE275932T1 (en) |
AU (1) | AU3270099A (en) |
BR (1) | BR9909064A (en) |
DE (1) | DE69920194T2 (en) |
GB (1) | GB2335596A (en) |
WO (1) | WO1999048471A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2354438A (en) * | 1999-09-23 | 2001-03-28 | Procter & Gamble | Polymer based compositions with anti-hydrolytic enzyme activity for use in pharmaceutical and cosmetic preparations |
US6794351B2 (en) | 2001-04-06 | 2004-09-21 | Kimberly-Clark Worldwide, Inc. | Multi-purpose cleaning articles |
US6897033B2 (en) | 2002-02-19 | 2005-05-24 | The Procter & Gamble Company | Fungal lipase |
US7101889B2 (en) | 2002-02-19 | 2006-09-05 | The Procter & Gamble | Lipase inhibiting composition |
WO2009102837A3 (en) * | 2008-02-15 | 2010-06-10 | The Procter & Gamble Company | Absorbent article with lotion comprising a polypropylene glycol material |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2354439A (en) * | 1999-09-23 | 2001-03-28 | Procter & Gamble | Skin care compositional |
US9035123B2 (en) * | 2002-10-01 | 2015-05-19 | The Procter & Gamble Company | Absorbent article having a lotioned topsheet |
US20040197292A1 (en) * | 2003-04-04 | 2004-10-07 | The Procter & Gamble Company | Personal care composition containing an antidandruff component and a nonionic surfactant |
US20040202636A1 (en) * | 2003-04-11 | 2004-10-14 | Kaczvinsky Joseph Robert | Personal care composition containing an antidandruff component and a nonionic surfactant |
US20040197287A1 (en) * | 2003-04-04 | 2004-10-07 | The Procter & Gamble Company | Personal care composition containing an antidandruff component and a nonionic surfactant |
DE102011086019A1 (en) | 2011-11-09 | 2012-08-02 | Henkel Ag & Co. Kgaa | Cosmetic product useful for preventing body odor, comprises composition comprising antiperspirant or deodorant active substance, water, and agent for dissolving or suspending active substance, propellant, and aerosol dispensing device |
DE102011087662A1 (en) | 2011-12-02 | 2013-06-06 | Henkel Ag & Co. Kgaa | Cosmetic aerosol spray with lasting freshness effect |
DE102011087980A1 (en) | 2011-12-08 | 2012-09-06 | Henkel Kgaa | Cosmetic and non-therapeutic use of platycodin e.g. for influencing natural pigmentation process of hair and its follicles in armpit region, for reducing shaving or epilation frequency, and as active substance in topically applied agents |
DE102011088967A1 (en) | 2011-12-19 | 2013-06-20 | Henkel Ag & Co. Kgaa | Deodorants and antiperspirants with stabilized antioxidant |
DE102011089012A1 (en) | 2011-12-19 | 2013-06-20 | Henkel Ag & Co. Kgaa | Textile-friendly antiperspirants |
DE102011089340A1 (en) | 2011-12-21 | 2013-06-27 | Henkel Ag & Co. Kgaa | PEG-free antiperspirant oil-in-water emulsions with improved feel |
DE102011089430A1 (en) | 2011-12-21 | 2012-08-23 | Henkel Ag & Co. Kgaa | Use of a specified hydrocarbon, obtained from non-fossil biomass, as a blowing agent for spray products, preferably a cosmetic product, pharmaceutical product, air care product, home care product or a product for the car or paint care |
DE102011089560A1 (en) | 2011-12-22 | 2013-06-27 | Henkel Ag & Co. Kgaa | Antiperspirant suspension spray with improved drug release and reduced textile soiling |
US9393197B2 (en) | 2012-06-29 | 2016-07-19 | Kimberly-Clark Worldwide, Inc. | Stable emulsion for prevention of skin irritation and articles using same |
US9949902B2 (en) | 2012-06-29 | 2018-04-24 | Kimberly-Clark Worldwide, Inc. | Stable emulsion for prevention of skin irritation and items using same |
US9511006B2 (en) | 2012-06-29 | 2016-12-06 | Kimberly-Clark Worldwide, Inc. | Dispersible moist wipe with emulsion for prevention of skin irritation |
DE102012222692A1 (en) | 2012-12-11 | 2013-09-05 | Henkel Ag & Co. Kgaa | Cosmetic composition useful as antiperspirant and deodorant, comprises 2-benzylheptan-1-ol, and rosemary extract |
DE102012224156A1 (en) | 2012-12-21 | 2014-06-26 | Henkel Ag & Co. Kgaa | Textile-friendly nonaerosol antiperspirants with hydroxycarboxylic acids |
DE102012224142A1 (en) | 2012-12-21 | 2014-06-26 | Henkel Ag & Co. Kgaa | Textile-friendly antiperspirant sprays with methanesulfonic acid |
DE102012224157A1 (en) | 2012-12-21 | 2014-06-26 | Henkel Ag & Co. Kgaa | Textile-friendly antiperspirant sprays with hydroxycarboxylic acids |
DE102012224133A1 (en) | 2012-12-21 | 2014-06-26 | Henkel Ag & Co. Kgaa | Textile-friendly nonaerosol antiperspirants with methanesulfonic acid |
DE102014217316A1 (en) | 2014-08-29 | 2016-03-03 | Henkel Ag & Co. Kgaa | Low-electrolyte preparations against body odor |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3018132A1 (en) * | 1980-05-12 | 1981-11-19 | Henkel Kgaa | Anti-acne and deodorant skin-care preparations - contg. amino:methylene-malonic acid derivs. which inhibit esterase and lipase enzymes secretions from skin bacteria |
JPS6112616A (en) * | 1984-06-29 | 1986-01-21 | Shiseido Co Ltd | Dermal drug for external use |
EP0117613B1 (en) * | 1983-01-24 | 1990-06-06 | The Procter & Gamble Company | Disposable absorbent article incorporating agents for the treatment and prophylaxis of diaper rash and diaper dermatitis |
WO1995016433A1 (en) * | 1993-12-14 | 1995-06-22 | Scophysa | Novel foaming compositions, particularly for rectal foams, and resulting foams |
JPH0853337A (en) * | 1994-08-11 | 1996-02-27 | Shiseido Co Ltd | Sebum suppressing agent |
JPH08268882A (en) * | 1995-04-03 | 1996-10-15 | Nippon Flour Mills Co Ltd | Inhibitor of lipase |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5362425A (en) * | 1992-10-22 | 1994-11-08 | Technology Unlimited, Inc. | Organic oil spray-drying techniques |
WO1995001155A1 (en) * | 1993-07-01 | 1995-01-12 | Unilever N.V. | Oral compositions |
GB9423180D0 (en) * | 1994-11-17 | 1995-01-04 | Procter & Gamble | Cosmetic compositions in stick form |
AU6482596A (en) * | 1995-07-03 | 1997-02-05 | Wilson T. Crandall | Transdermal and oral treatment of androgenic alopecia |
US5944754A (en) * | 1995-11-09 | 1999-08-31 | University Of Massachusetts | Tissue re-surfacing with hydrogel-cell compositions |
WO1997021441A1 (en) * | 1995-12-11 | 1997-06-19 | Mdv Technologies, Inc. | Ophthalmic composition comprising polyoxyethylene-polyoxypropylene polymers |
-
1998
- 1998-03-24 GB GB9806235A patent/GB2335596A/en not_active Withdrawn
-
1999
- 1999-03-22 BR BR9909064-3A patent/BR9909064A/en not_active Application Discontinuation
- 1999-03-22 WO PCT/IB1999/000476 patent/WO1999048471A1/en active IP Right Grant
- 1999-03-22 AU AU32700/99A patent/AU3270099A/en not_active Abandoned
- 1999-03-22 EP EP99942578A patent/EP1066025B1/en not_active Expired - Lifetime
- 1999-03-22 AT AT99942578T patent/ATE275932T1/en not_active IP Right Cessation
- 1999-03-22 CN CN99804006A patent/CN1295460A/en active Pending
- 1999-03-22 JP JP2000537522A patent/JP2002507559A/en active Pending
- 1999-03-22 US US09/646,292 patent/US6461601B1/en not_active Expired - Fee Related
- 1999-03-22 DE DE69920194T patent/DE69920194T2/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3018132A1 (en) * | 1980-05-12 | 1981-11-19 | Henkel Kgaa | Anti-acne and deodorant skin-care preparations - contg. amino:methylene-malonic acid derivs. which inhibit esterase and lipase enzymes secretions from skin bacteria |
EP0117613B1 (en) * | 1983-01-24 | 1990-06-06 | The Procter & Gamble Company | Disposable absorbent article incorporating agents for the treatment and prophylaxis of diaper rash and diaper dermatitis |
JPS6112616A (en) * | 1984-06-29 | 1986-01-21 | Shiseido Co Ltd | Dermal drug for external use |
WO1995016433A1 (en) * | 1993-12-14 | 1995-06-22 | Scophysa | Novel foaming compositions, particularly for rectal foams, and resulting foams |
JPH0853337A (en) * | 1994-08-11 | 1996-02-27 | Shiseido Co Ltd | Sebum suppressing agent |
JPH08268882A (en) * | 1995-04-03 | 1996-10-15 | Nippon Flour Mills Co Ltd | Inhibitor of lipase |
Non-Patent Citations (5)
Title |
---|
DATABASE WPI Week 8609, Derwent World Patents Index; AN 86-059665, XP002105073 * |
DATABASE WPI Week 9618, Derwent World Patents Index; AN 96-175655, XP002105071 * |
DATABASE WPI Week 9651, Derwent World Patents Index; AN 96-514901, XP002105072 * |
KAREN COMAI ET AL.: "Antiobesity activity of pluronic L-101", INTERNATIONAL JOURNAL OBESITY, vol. 4, no. 1, 1980, pages 33 - 42, XP002105070 * |
THOMAS P. JOHNSTON ET AL.: "Mechanism of poloxamer 407- induced hypertriglyceridemia in the rat", BIOCHEM. PHARMACOLOGY, vol. 46, no. 6, 1993, pages 1037 - 42, XP002105069 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2354438A (en) * | 1999-09-23 | 2001-03-28 | Procter & Gamble | Polymer based compositions with anti-hydrolytic enzyme activity for use in pharmaceutical and cosmetic preparations |
US6794351B2 (en) | 2001-04-06 | 2004-09-21 | Kimberly-Clark Worldwide, Inc. | Multi-purpose cleaning articles |
US6897033B2 (en) | 2002-02-19 | 2005-05-24 | The Procter & Gamble Company | Fungal lipase |
US7101889B2 (en) | 2002-02-19 | 2006-09-05 | The Procter & Gamble | Lipase inhibiting composition |
WO2009102837A3 (en) * | 2008-02-15 | 2010-06-10 | The Procter & Gamble Company | Absorbent article with lotion comprising a polypropylene glycol material |
CN101945674B (en) * | 2008-02-15 | 2013-11-27 | 宝洁公司 | Absorbent article with lotion comprising polypropylene glycol material |
Also Published As
Publication number | Publication date |
---|---|
DE69920194D1 (en) | 2004-10-21 |
US6461601B1 (en) | 2002-10-08 |
JP2002507559A (en) | 2002-03-12 |
BR9909064A (en) | 2000-12-05 |
ATE275932T1 (en) | 2004-10-15 |
GB9806235D0 (en) | 1998-05-20 |
AU3270099A (en) | 1999-10-18 |
EP1066025B1 (en) | 2004-09-15 |
EP1066025A1 (en) | 2001-01-10 |
CN1295460A (en) | 2001-05-16 |
GB2335596A (en) | 1999-09-29 |
DE69920194T2 (en) | 2005-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6461601B1 (en) | Polyalkoxy copolymers as lipase inhibitors and their compositions | |
RU2465891C2 (en) | Antibacterial compositions, products and methods of their application | |
RU2272612C2 (en) | Compositions showing enhanced precipitation of active compound for regional effect on surface | |
AU2012242682B2 (en) | Sodium hypochlorite-based body wash compositions | |
US20090035339A1 (en) | Methods of Inactivating Viruses | |
JP2005530857A (en) | Antibacterial compositions, antibacterial products, and methods of using them | |
US6951833B2 (en) | Anti-microbial compositions | |
KR20090122997A (en) | Drug solution for cleaning wet sheet and cleaning wet sheet containing the same | |
EA038526B1 (en) | Antimicrobial composition comprising oligodynamic metal | |
ES2241371T3 (en) | TOPICA VITAMIN COMPOSITION. | |
WO1999026610A1 (en) | Skin care composition | |
AU751930B2 (en) | Anti-enzyme compositions comprising ethylenediamine disuccinic acid | |
JPH06157291A (en) | Skin cleaning agent containing embryo bud of rice | |
MXPA00009329A (en) | Polyalkoxy copolymers as lipase inhibitors and their compositions | |
JP2001302495A (en) | Skin-cleansing agent and skin-cleansing supplies | |
KR970002055B1 (en) | Liquid detergent composition | |
GB2354438A (en) | Polymer based compositions with anti-hydrolytic enzyme activity for use in pharmaceutical and cosmetic preparations | |
GB2354439A (en) | Skin care compositional | |
EA041341B1 (en) | ANTIMICROBIAL COMPOSITIONS FOR APPLICATION TO HUMAN SKIN | |
AU2008200754A1 (en) | Antimicrobial compositions, products and methods employing same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99804006.1 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BR CN ID JP MX US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 09646292 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 32700/99 Country of ref document: AU Ref document number: PA/a/2000/009329 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999942578 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999942578 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1999942578 Country of ref document: EP |